{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:19:05Z","timestamp":1777393145141,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006451","name":"Hospices Civils de Lyon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006451","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-025-00776-w","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:48:47Z","timestamp":1738244927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Poor efficacy of the combination of clarithromycin, amikacin, and cefoxitin against Mycobacterium abscessus in the hollow fiber infection model"],"prefix":"10.1186","volume":"24","author":[{"given":"Etienne","family":"Vignaud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Goutelle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Genestet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Guitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Bourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurore","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Lebouteiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albin","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Richet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Dumitrescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Hodille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"776_CR1","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.3390\/jcm9082541","volume":"9","author":"K To","year":"2020","unstructured":"To K, Cao R, Yegiazaryan A, Owens J, Venketaraman V. General overview of nontuberculous mycobacteria opportunistic pathogens: Mycobacterium avium and Mycobacterium abscessus. J Clin Med. 2020;9:2541.","journal-title":"J Clin Med"},{"key":"776_CR2","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3201\/2109.141634","volume":"21","author":"M-R Lee","year":"2015","unstructured":"Lee M-R, Sheng W-H, Hung C-C, Yu C-J, Lee L-N, Hsueh P-R. Mycobacterium abscessus complex infections in humans. Emerg Infect Dis. 2015;21:1638\u201346.","journal-title":"Emerg Infect Dis"},{"key":"776_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367\u2013416.","journal-title":"Am J Respir Crit Care Med"},{"key":"776_CR4","doi-asserted-by":"publisher","first-page":"2000535","DOI":"10.1183\/13993003.00535-2020","volume":"56","author":"CL Daley","year":"2020","unstructured":"Daley CL, Iaccarino JM, Lange C, Cambau E, Wallace RJ, Andrejak C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur Respir J. 2020;56:2000535.","journal-title":"Eur Respir J"},{"key":"776_CR5","doi-asserted-by":"publisher","first-page":"4471","DOI":"10.1099\/ijsem.0.001376","volume":"66","author":"E Tortoli","year":"2016","unstructured":"Tortoli E, Kohl TA, Brown-Elliott BA, Trovato A, Le\u00e3o SC, Garcia MJ, et al. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. Nov. Int J Syst Evol Microbiol. 2016;66:4471\u20139.","journal-title":"Int J Syst Evol Microbiol"},{"key":"776_CR6","doi-asserted-by":"publisher","first-page":"e01206","DOI":"10.1128\/AAC.01206-17","volume":"61","author":"JG Pasipanodya","year":"2017","unstructured":"Pasipanodya JG, Ogbonna D, Ferro BE, Magombedze G, Srivastava S, Deshpande D, et al. Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence. Antimicrob Agents Chemother. 2017;61:e01206-e1217.","journal-title":"Antimicrob Agents Chemother"},{"key":"776_CR7","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1128\/AAC.00990-16","volume":"60","author":"BE Ferro","year":"2016","unstructured":"Ferro BE, Srivastava S, Deshpande D, Pasipanodya JG, van Soolingen D, Mouton JW, et al. Failure of the Amikacin, Cefoxitin, and Clarithromycin combination regimen for treating pulmonary Mycobacterium abscessus infection. Antimicrob Agents Chemother. 2016;60:6374\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"776_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1183\/09031936.94.07071275","volume":"7","author":"D Honeybourne","year":"1994","unstructured":"Honeybourne D, Kees F, Andrews JM, Baldwin D, Wise R. The levels of clarithromycin and its 14-hydroxy metabolite in the lung. Eur Respir J. 1994;7:1275\u201380.","journal-title":"Eur Respir J"},{"key":"776_CR9","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1128\/AAC.41.6.1399","volume":"41","author":"KA Rodvold","year":"1997","unstructured":"Rodvold KA, Gotfried MH, Danziger LH, Servi RJ. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother. 1997;41:1399\u2013402.","journal-title":"Antimicrob Agents Chemother"},{"key":"776_CR10","unstructured":"Clinical and laboratory standards institute. M24\u2014susceptibility testing of Mycobacteria, Nocardia spp, and other aerobic actinomycetes. 3rd edn. 2018."},{"key":"776_CR11","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/jac\/dkab160","volume":"76","author":"Z Sadouki","year":"2021","unstructured":"Sadouki Z, McHugh TD, Aarnoutse R, Ortiz Canseco J, Darlow C, Hope W, et al. Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting. J Antimicrob Chemother. 2021;76:2252\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"776_CR12","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit\u2014ZECLAR 0.5 g, poudre pour solution \u00e0 diluer pour perfusion. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=61433564&typedoc=R#RcpPropPharmacocinetiques. Accessed 19 Jul 2024."},{"key":"776_CR13","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit\u2014AMIKACINE VIATRIS 1 g, poudre pour solution injectable en flacon. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=62516778&typedoc=R#RcpPropPharmacocinetiques. Accessed 19 Jul 2024."},{"key":"776_CR14","unstructured":"Base de donn\u00e9es publique des m\u00e9dicaments. R\u00e9sum\u00e9 des caract\u00e9ristiques du produit\u2014CEFOXITINE PANPHARMA 1 g, poudre pour solution injectable (IV). https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=69084488&typedoc=R#RcpPropPharmacocinetiques. Accessed 19 Jul 2024."},{"key":"776_CR15","unstructured":"The European Committee on Antimicrobial Susceptibility, EUCAST. Amikacin: Rationale for EUCAST Clinical Breakpoints. 2024. https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Rationale_documents\/Amikacin_Rationale_Document_v_3.1_20240901.pdf. Accessed 22 Nov 2024."},{"issue":"Suppl A","key":"776_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0195-6701(91)90215-T","volume":"19","author":"PG Davey","year":"1991","unstructured":"Davey PG. The pharmacokinetics of clarithromycin and its 14-OH metabolite. J Hosp Infect. 1991;19(Suppl A):29\u201337.","journal-title":"J Hosp Infect"},{"key":"776_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00228-011-1206-1","volume":"68","author":"A Isla","year":"2012","unstructured":"Isla A, Troc\u00f3niz IF, de Tejada IL, V\u00e1zquez S, Canut A, L\u00f3pez JM, et al. Population pharmacokinetics of prophylactic cefoxitin in patients undergoing colorectal surgery. Eur J Clin Pharmacol. 2012;68:735\u201345.","journal-title":"Eur J Clin Pharmacol"},{"key":"776_CR18","unstructured":"Clinical and laboratory standards institute. M62\u2014performance standards for susceptibility testing of Mycobacetria, Nocardia spp., and other aerobic actinomycetes. 1st edn. 2018."},{"key":"776_CR19","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1086\/515328","volume":"177","author":"T Prammananan","year":"1998","unstructured":"Prammananan T, Sander P, Brown BA, Frischkorn K, Onyi GO, Zhang Y, et al. A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae. J Infect Dis. 1998;177:1573\u201381.","journal-title":"J Infect Dis"},{"key":"776_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","volume":"17","author":"NQ Balaban","year":"2019","unstructured":"Balaban NQ, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson DI, et al. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol. 2019;17:441\u20138.","journal-title":"Nat Rev Microbiol"},{"key":"776_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner A, Fridman O, Gefen O, Balaban NQ. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol. 2016;14:320\u201330.","journal-title":"Nat Rev Microbiol"},{"key":"776_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.617412","volume":"12","author":"JE Sulaiman","year":"2021","unstructured":"Sulaiman JE, Lam H. Evolution of bacterial tolerance under antibiotic treatment and its implications on the development of resistance. Front Microbiol. 2021;12: 617412.","journal-title":"Front Microbiol"},{"key":"776_CR23","first-page":"e01456","volume":"68","author":"C Bernard","year":"2024","unstructured":"Bernard C, Liu Y, Larrouy-Maumus G, Guilhot C, Cam K, Chalut C. Altered serine metabolism promotes drug tolerance in Mycobacterium abscessus via a WhiB7-mediated adaptive stress response. Antimicrob Agents Chemother. 2024;68:e01456-e1523.","journal-title":"Antimicrob Agents Chemother"},{"key":"776_CR24","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/IAI.69.5.2996-3003.2001","volume":"69","author":"S Herbert","year":"2001","unstructured":"Herbert S, Barry P, Novick RP. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun. 2001;69:2996\u20133003.","journal-title":"Infect Immun"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-025-00776-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T13:48:50Z","timestamp":1738244930000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-025-00776-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["776"],"URL":"https:\/\/doi.org\/10.1186\/s12941-025-00776-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5064595\/v1","asserted-by":"object"}]},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}